Somatrem

From Wikipedia, the free encyclopedia
(Redirected from Protropin)

Template:Short description

Page Module:Message box/ambox.css has no content.

Template:Short description Page Template:Infobox drug/styles.css has no content.

Page Module:Infobox/styles.css has no content.

Somatrem
Clinical data
Trade namesProtropin
AHFS/Drugs.comMicromedex Detailed Consumer Information
ATC codePage Template:Plainlist/styles.css has no content.
Identifiers
CAS NumberPage Template:Plainlist/styles.css has no content.
PubChem CIDPage Template:Plainlist/styles.css has no content.
PubChem SIDPage Template:Plainlist/styles.css has no content.
IUPHAR/BPSPage Template:Plainlist/styles.css has no content.
DrugBankPage Template:Plainlist/styles.css has no content.
ChemSpiderPage Template:Plainlist/styles.css has no content.
UNIIPage Template:Plainlist/styles.css has no content.
KEGGPage Template:Plainlist/styles.css has no content.
ChEBIPage Template:Plainlist/styles.css has no content.
ChEMBLPage Template:Plainlist/styles.css has no content.
NIAID ChemDBPage Template:Plainlist/styles.css has no content.
PDB ligandPage Template:Plainlist/styles.css has no content.
CompTox Dashboard (EPA)Page Template:Plainlist/styles.css has no content.
Chemical and physical data
FormulaC995H1537N263O301S8
Molar mass22256.26 g·mol−1
3D model (JSmol)Page Template:Plainlist/styles.css has no content.
Data page
Template:Infobox drug/data page link
Page Template:Nobold/styles.css has no content. ☒NcheckY (what is this?)Page Template:Nobold/styles.css has no content.  (verify)

Somatrem, sold under the brand name Protropin, is an analogue of growth hormone (GH).[1]

Overview

Somatrem is a recombinant human growth hormone used for the treatment of short stature due to decreased or absent secretion of endogenous growth hormone.

Somatrem was first marketed under the brand name Protropin by Genentech in 1985.[2] It differs from endogenous growth hormone by the addition of an extra methionine at the N-terminus[3][circular reference].

Somatrem has largely been replaced by somatropin, marketed by several companies including by Genentech as the brand Nutropin.

References

Page Template:Reflist/styles.css has no content.

  1. ^ Page Module:Citation/CS1/styles.css has no content.Flodh H (1987). "Present situation worldwide regarding the use and clinical experience of Somatonorm (somatrem)". Acta Paediatrica Scandinavica. Supplement. 331: 1–4. doi:10.1111/j.1651-2227.1987.tb17089.x. PMID 3300150. S2CID 20410776.
  2. ^ Page Module:Citation/CS1/styles.css has no content."Genentech: Press Releases - Friday, Oct 18, 1985". www.gene.com.
  3. ^ Growth hormone therapy#cite note-32

Template:GH/IGF-1 axis signaling modulators Lua error in package.lua at line 80: module 'Module:Navbox/configuration' not found. Lua error in mw.title.lua at line 404: bad argument #2 to 'title.new' (unrecognized namespace name 'Portal').

Template:Asbox

Retrieved from "https://cosmopedia.co/index.php?title=Somatrem&oldid=6106181"